Methylergometrine Maleate
马来酸甲麦角新碱
Report date: 2026/03/17 16:09:30
NME
Base Information
Drug NameMethylergometrine Maleate
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1971/05/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesAska Pharmaceutical Co LtdSunstone (Tangshan) Pharmaceutical Co LtdLianyisheng (Beijing) Pharmaceutical Technology Co Ltd +[4]
Inactive CompaniesJohns Hopkins UniversityEdison Theraps Llc
Active Indications
Inactive Indications